Unlock Your Investor Data With DealMaker’s API

May 16, 2022

Integrate your existing tech stack and empower your capital raise with DealMaker's API

‍

With the launch of our new API, any tech-driven organization on our platform can now integrate DealMaker directly into their existing tech stack. Analysts can gain investor insights, developers can let users begin their investment within their own website, and upcoming features will empower your entire organization with meaningful data.

What does the DealMaker API do?

First, what is an API? An API, or Application Programming Interface, is a connection between computers or computer programs (typically in real-time or near real-time). Today, talk of APIs usually refer to web APIs, which allow data to move between different apps or websites. Whether it's stock prices or the weather, so much of the information we consume daily travels from one company to another - behind the scenes - feeling seamless to the end-user...

DealMaker's API does just that. It allows your investors to have a seamless experience within your platform and gives organizations with a robust digital investor experience even more power:

Flexible and customizable access to investor data in near real-time, during your raise
Ability to analyze and project results based on cadence of interest and amounts invested
Retrieve high-level stats about the progress of your raise

Creating an investor directly from your platform

The DealMaker API meets a common request from ambitious technology- and data-driven organizations. Prior to sending their users to the DealMaker platform, those high-performing teams can harness the API to capture an investor's email and name directly on their site–a subtle change that decreases steps to conversion and reduces user interface friction for their investors.

Real-time updates–get set up the very next day

Any development team, large or small, can be set up the very next day after a 30-minute call.

Depending on your specific needs, and your organization’s resources, your deals can use sophisticated actions that incorporate our existing webhooks like high-level, real time progress of deals.

Want to bring investor info into your existing CRM? Create dashboards that are perfectly tailored for your team by integrating the current DealMaker API functionalities into your organization's Zapier, Hubspot or CRM.

Future of the API

We're continually innovating and expanding our product roadmap, just like the organizations using DealMaker’s technology to run streamlined capital raises. The upcoming product enhancement focuses on leveraging the API to make our internal processes more efficient, and support organizations like yours even better.

‍

But the DealMaker platform has come a long way since the idea of developing an API sprang years ago to when it was initially fleshed out earlier this year. With the API’s launch, possibilities are limited only by the imagination of your teams–from organizations building customizable questionnaire flows, analysts creating detailed investor profiles, to even growing an app ecosystem.

Let’s shape the future of digital capital raising

‍

Be one of the first users of the API! Submit your interest at www.dealmaker.tech/api and share the DealMaker API docs with your developers. Empower your teams, enhance your tech stack, and serve your investors anywhere you want.

‍

Monogram Case Study - DealMaker (Embed)

When VCs said no, Monogram turned to retail investors. That decision powered their rise from startup to publicly traded company—and even helped them raise an additional $13M privately after their Nasdaq debut.

The Challenge: Raising Capital on Their Terms

The Challenge: Raising on Their Terms

Monogram Technologies was founded with a bold vision: to revolutionize orthopedic surgery with a robotic joint replacement system using custom 3D-printed joints. The market for this technology is massive—approximately $19.6 billion, with over 1 million knee replacements per year. But it's a capital-intensive, regulation-heavy space—and traditional VCs weren't biting.

Instead of compromising, co-founders Dr. Doug Unis and Ben Sexson went all-in on a different path: retail capital. Why?

Control and ownership: Not only were they able to raise the capital they needed to grow the business—they did it on their own terms.
Long-term asset: They wanted to build an army of true believers who wanted to see the company succeed and would continue to reinvest over the years.
A value-add network: Raising from retail allowed Monogram to amass a waiting list of thousands of patients eager to participate in future trials.
Aligned incentives: Their mission to improve patient outcomes and build a better future for those struggling with joint pain resonated with retail investors.

The Power of Retail: Monogram's Capital Journey

Start Date	End Date	Type	Platform	Amount Raised	# Investors
3/13/19	3/31/20	A+	SeedInvest	$14,588,668	6,000
11/16/20	1/16/21	A+	StartEngine	$2,965,501	8,000
1/17/21	2/18/22	A+	StartEngine	$23,647,853	14,082
7/15/22	3/16/23	CF	DealMaker	$4,673,000	2,249
3/1/23	4/8/23	A+	Republic	$232,275	120
3/1/23	5/23/23	A+	DealMaker	$15,958,364	5,198
5/18/23	-	Nasdaq listing
7/24	10/24	Unit Offering	DealMaker	$12,990,103	2,745

Monogram Capital Raise Timeline

Monogram's first direct-to-investor raise was a $14.6M round in 2019. Since then, Monogram has raised retail capital six additional times, using Reg A+ as a springboard to a Nasdaq listing in 2023.

Each raise brought in new believers—and more importantly, kept bringing them back. That's the long-term power of retail capital. It's not just one campaign—it's a compounding asset that grows with the business.

$80M+

Raised across seven campaigns

~40,000

Investors championing Monogram's vision

20%

Of each raise came from previous investors

Marketing Excellence

DealMaker Reach provided strategic investor acquisition services, helping Monogram connect with the right audience through high-impact channels.

Premium Publications

Targeted campaigns in premium publications like Morning Brew captured qualified investors

High-Engagement Webinars

Engaging events that generated over $4.3 million in investments

Community Building

Strategic approaches that fostered a loyal shareholder base

Investment Momentum

Innovative approaches that amplified investment momentum

Monogram's Journey to Success

Monogram's journey has been defined by relentless innovation, strategic fundraising, and breakthrough advancements in robotic-assisted joint replacement. From early-stage research to a Nasdaq listing and beyond, Monogram's milestones reflect its evolution into a pioneering force in orthopedic surgery:

Filed its first patent application in 2017
Conducted clinical studies at UCLA and University of Nebraska
Expanded the team with key hires
Attracted a top-tier advisory board to guide clinical innovations
Signed their first distribution partnerships
Made headlines with cutting-edge live demonstrations
Secured 501(k) FDA clearance for the mBôs surgical system

Nasdaq Debut & Beyond

In May 2023, Monogram Orthopaedics successfully listed on the Nasdaq—a significant milestone offering liquidity and growth opportunities for the company.

For most companies, that would be the end of their story in the private markets. But for Monogram, it was just the beginning of a new chapter.

Public perception says you can't raise privately post-IPO. Monogram proved that wrong.

Defying conventional fundraising norms, Monogram raised an additional $13 million from private investors, powered by DealMaker. This move highlighted the power of a dedicated investor community and provided additional strategic growth capital. Meanwhile, strategic digital marketing for the private offering helped boost the public share price—a win-win for the company and its investors, both public and private.

This was retail capital at its best: strategic, repeatable, and aligned.

One vision. Zero compromises.

This wasn't a one-time raise. It was a multi-year capital strategy.

Retail capital helped Monogram:

Go from concept to commercialization without relying on VCs
Retain ownership and control in a high-burn industry
Build a base of loyal shareholders who invested not once, but over and over again
Uplist to the Nasdaq, and still keep raising post-IPO

This is what makes retail capital different. It doesn't expire—it compounds. And DealMaker is built to maximize that long-term value.

Ready to Raise Capital on Your Terms?

Whether you're pre-revenue or post-IPO, DealMaker gives you the infrastructure, support, and strategy to raise from the people who believe in you most.

Explore Raising Capital with DealMaker